News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
591,032 Results
Type
Article (44019)
Company Profile (168)
Press Release (546822)
Multimedia
Podcasts (147)
Webinars (20)
Section
Business (163873)
Career Advice (1641)
Deals (28272)
Drug Delivery (142)
Drug Development (75073)
Employer Resources (123)
FDA (12910)
Job Trends (11406)
News (285097)
Policy (26692)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (1873)
Accelerated approval (39)
Adcomms (33)
Allergies (152)
Alliances (44054)
ALS (180)
Alzheimer's disease (1488)
Antibody-drug conjugate (ADC) (414)
Approvals (13202)
Artificial intelligence (495)
Autoimmune disease (266)
Automation (29)
Bankruptcy (251)
Best Places to Work (8302)
BIOSECURE Act (20)
Biosimilars (222)
Biotechnology (83)
Bladder cancer (157)
Brain cancer (63)
Breast cancer (548)
Cancer (4654)
Cardiovascular disease (421)
Career advice (1388)
Career pathing (43)
CAR-T (293)
CDC (43)
Celiac Disease (2)
Cell therapy (723)
Cervical cancer (33)
Clinical research (65595)
Collaboration (1680)
Company closure (6)
Compensation (787)
Complete response letters (83)
COVID-19 (2416)
CRISPR (83)
C-suite (948)
Cystic fibrosis (129)
Data (6634)
Decentralized trials (3)
Denatured (32)
Depression (162)
Dermatology (66)
Diabetes (477)
Diagnostics (4217)
Digital health (30)
Diversity (10)
Diversity, equity & inclusion (35)
Drug discovery (265)
Drug pricing (224)
Drug shortages (36)
Duchenne muscular dystrophy (242)
Earnings (62148)
Editorial (69)
Employer branding (16)
Employer resources (117)
Events (94835)
Executive appointments (931)
FDA (15811)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (22)
Funding (1322)
Gene editing (183)
Generative AI (46)
Gene therapy (599)
GLP-1 (1078)
Government (3630)
Grass and pollen (6)
Guidances (327)
Healthcare (12019)
HIV (71)
Huntington's disease (51)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (93)
Immunology and inflammation (295)
Immuno-oncology (79)
Indications (165)
Infectious disease (2710)
Inflammatory bowel disease (195)
Inflation Reduction Act (13)
Influenza (121)
Intellectual property (233)
Interviews (266)
IPO (11565)
IRA (54)
Job creations (3355)
Job search strategy (1176)
JPM (63)
Kidney cancer (20)
Labor market (83)
Layoffs (517)
Leadership (39)
Legal (6400)
Liver cancer (76)
Longevity (18)
Lung cancer (627)
Lymphoma (409)
Machine learning (40)
Management (44)
Manufacturing (877)
MASH (188)
Medical device (7208)
Medtech (7270)
Mergers & acquisitions (17652)
Metabolic disorders (1409)
mRNA (200)
Multiple sclerosis (172)
NASH (23)
Neurodegenerative disease (349)
Neuropsychiatric disorders (108)
Neuroscience (2834)
Neurotech (1)
NextGen: Class of 2026 (4328)
Non-profit (2524)
Now hiring (63)
Obesity (712)
Opinion (321)
Ovarian cancer (172)
Pain (230)
Pancreatic cancer (216)
Parkinson's disease (318)
Partnered (27)
Patents (474)
Patient recruitment (551)
Peanut (50)
People (54333)
Pharmaceutical (80)
Pharmacy benefit managers (36)
Phase 1 (20398)
Phase 2 (28780)
Phase 3 (21825)
Pipeline (7023)
Policy (318)
Postmarket research (2337)
Preclinical (7939)
Press Release (46)
Prostate cancer (235)
Psychedelics (54)
Radiopharmaceuticals (293)
Rare diseases (943)
Real estate (4940)
Recruiting (52)
Regulatory (21112)
Reports (34)
Research institute (1796)
Resumes & cover letters (248)
Rett syndrome (19)
RNA editing (18)
RSV (77)
Schizophrenia (175)
Series A (226)
Series B (224)
Service/supplier (9)
Sickle cell disease (105)
Special edition (28)
Spinal muscular atrophy (170)
Sponsored (34)
Startups (3478)
State (2)
Stomach cancer (16)
Supply chain (106)
Tariffs (100)
The Weekly (112)
Vaccines (940)
Venture capital (106)
Weight loss (508)
Women's health (83)
Worklife (17)
Date
Today (90)
Last 7 days (734)
Last 30 days (2467)
Last 365 days (23643)
2026 (8947)
2025 (23827)
2024 (27198)
2023 (30414)
2022 (40199)
2021 (43083)
2020 (39943)
2019 (32462)
2018 (24994)
2017 (27894)
2016 (28791)
2015 (34093)
2014 (27292)
2013 (23381)
2012 (24758)
2011 (24775)
2010 (22583)
Location
Africa (750)
Alabama (63)
Alaska (3)
Arizona (194)
Arkansas (13)
Asia (42824)
Australia (6506)
California (9359)
Canada (2935)
China (1261)
Colorado (411)
Connecticut (390)
Delaware (309)
Europe (86687)
Florida (1468)
Georgia (298)
Hawaii (2)
Idaho (33)
Illinois (808)
India (87)
Indiana (429)
Iowa (12)
Japan (493)
Kansas (112)
Kentucky (38)
Louisiana (22)
Maine (30)
Maryland (1107)
Massachusetts (7010)
Michigan (204)
Minnesota (498)
Mississippi (5)
Missouri (80)
Montana (24)
Nebraska (21)
Nevada (108)
New Hampshire (34)
New Jersey (2882)
New Mexico (25)
New York (2595)
North Carolina (1337)
North Dakota (4)
Northern California (4688)
Ohio (253)
Oklahoma (12)
Oregon (31)
Pennsylvania (1862)
Puerto Rico (28)
Rhode Island (37)
South America (1055)
South Carolina (41)
South Dakota (1)
Southern California (3770)
Tennessee (109)
Texas (1385)
United States (33763)
Utah (218)
Virginia (265)
Washington D.C. (70)
Washington State (811)
West Virginia (2)
Wisconsin (87)
Wyoming (1)
591,032 Results for "pharma two b ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
February 26, 2026
·
8 min read
Press Releases
Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings
May 10, 2026
·
3 min read
Mergers & acquisitions
Pharma Double-Dippers Lead Q1 Deal Activity to Nearly $47B
Deal-hungry Big Pharmas, a long-sought biotech prize, an infrequent buyer and one serial biotech rabblerouser highlight a busy quarter in biopharma M&A.
April 1, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
April 1, 2026
·
10 min read
Press Releases
Breckenridge Pharmaceutical enters strategic partnership with Maiva Pharma Pvt. Ltd.
March 11, 2026
·
2 min read
Mergers & acquisitions
Biogen Secures ‘Running Start’ in Kidney Disease With $5.6B Apellis Buy
In addition to delivering two approved medicines to Biogen’s portfolio, the acquisition of Apellis Pharmaceuticals will support the future launch of the pharma’s own kidney disease asset, currently in multiple Phase 3 trials.
March 31, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
March 10, 2026
·
9 min read
Deals
Sun Pharma beams up Organon in $11.75B acquisition
Sun Pharmaceutical is bringing Merck spinoff Organon into the fold, paying $11.75 billion in hopes of becoming a top global biosimilar player.
April 27, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Faron Pharmaceuticals Ltd: Directorate Appointment
May 5, 2026
·
3 min read
Mergers & acquisitions
UCB captures Candid in $2.2B autoimmune deal as pharma’s M&A train chugs along
Candid Therapeutics follows closely behind Neurona Therapeutics, which UCB acquired in mid-April in a potential $1.15 billion deal.
May 4, 2026
·
2 min read
·
Tristan Manalac
1 of 59,104
Next
